Journal article
Effect of Extended MMX Mesalamine Therapy for Acute, Mild-to-Moderate Ulcerative Colitis
Michael A Kamm, Gary R Lichtenstein, William J Sandborn, Stefan Schreiber, Kirstin Lees, Karen Barrett, Raymond Joseph
Inflammatory Bowel Diseases | JOHN WILEY & SONS INC | Published : 2009
DOI: 10.1002/ibd.20580
Grants
Funding Acknowledgements
This study was funded by Shire Pharmaceuticals Inc., USA